NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-139-2012-0-US-01 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US 61/651,961 Abandoned
NIDDK E-285-2008-1-US-01 Adenosine Receptor Agonists, Partial Agonists, and Antagonists US CIP 13/479,973 9181253 Issued PDF
NIAID E-154-2011-3-PCT-01 METHOD FOR INDUCING AN IMMUNE RESPONSE AND FORMULATIONS THEREOF PCT PCT COMB PCT/US2012/039473 Expired
NCI E-082-2014-0-PCT-02 ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS PCT PCT PCT/US2012/039365 Expired
NINDS E-206-2011-3-PCT-01 USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT DISEASES CHARACTERIZED BY LOSS OF PROTEIN FUNCTION PCT PCT COMB PCT/US2012/039405 Expired
NIDCR E-015-2002-3-JP-10 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP DIV 2011-116399 Abandoned
NIAID E-117-2006-0-US-08 BORIS Isoforms And Methods of Detecting And Treating Disease US DIV 13/478,779 8440415 Issued PDF
NIAID E-186-2011-1-PCT-01 Prime-Boost Vaccination For Viral Infection PCT PCT COMB PCT/US2012/039197 Expired
NCI E-105-2012-0-US-01 Murine Anti-NY-ESO-1 T Cell Receptors US 61/650,020 Abandoned
NINDS E-143-2002-1-US-15 METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS US CON 13/475,688 Abandoned
NHGRI E-187-2011-0-US-02 Methods For Detecting ADHD Susceptibility And Predicting Severity Ans Long Term Outcome of ADHD Symptoms US ORD 13/475,342 Abandoned
CC E-267-2011-0-US-01 Whole Heart Extracellular Volume Fraction/Volume Of Distribution By Low Dose Computed Tomography US 61/648,996 Abandoned
NCI E-164-2012-0-US-01 Nanoparticles With Enhanced Entry Into Cancer Cells US 61/648,735 Abandoned
NIAID E-140-2012-0-US-01 HIV-Neutralizing Polypeptides And Methods Of Their Use. US 61/649,150 Abandoned
NCI E-246-2003-1-US-09 Non-Peptide Antagonists Of Gastrin Releasing Peptide US DIV 13/473,507 Abandoned
NIAMS E-116-2005-0-US-04 Tissue Engineered Cartilage, Methods of Making Same, Theuraputics and Cosmetic Surgical Application Using Same US DIV 13/472,173 Abandoned
NIEHS E-080-2012-0-US-01 Use Of Antagonists Of Hyaluronan Signaling For Treatment Of Airway Inflammation And Hyperresponsiveness US 61/647,101 Abandoned
NCI E-014-2007-0-US-23 Smoothened Polypeptides And Methods Of Use US DIV 13/470,965 8546524 Abandoned PDF
NCI E-025-2010-0-EP-05 Diazeniumdiolated Compounds, Pharmaceutical Compositions, And Method of Treating Cancer EP National Stage 10778814.3 Abandoned
NCI E-273-2011-0-US-01 Cross Reactive Antibodies Against Dengue Virus And Uses Thereof US 61/646,638 Abandoned
NIA E-103-2011-2-CA-04 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS CA National Stage 2835825 Issued
NIA E-103-2011-2-EP-05 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS EP National Stage 12785169.9 Issued
NIA E-103-2011-2-JP-06 Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells JP National Stage 2014-510518 Issued
NIA E-103-2011-2-AU-03 Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells AU National Stage 2012256014 Issued
NIAID E-337-2004-0-AU-10 Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes AU DIV 2012202786 Issued
NIA E-103-2011-2-PCT-01 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS PCT PCT COMB PCT/US12/037643 Expired
NIA E-084-2011-1-PCT-02 COMPOSITIONS AND METHODS FOR INCREASING THE FREQUENCY OF HOMOLOGUS RECOMBINATION PCT PCT PCT/US12/037650 Expired
NHLBI E-249-2006-2-US-04 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device US DIV 13/468,761 9271833 Issued PDF
NCI E-081-2011-0-PCT-02 Tropolone Compounds For Treating Or Preventing Retroviral Infection PCT PCT PCT/US2012/037208 Expired
NIAID E-006-2010-1-US-02 Protection Against Pandemic and Seasonal Strains Of Influenza US National Stage 13/500,421 Abandoned
NIA E-260-2011-0-US-01 SYNTHESIS OF FLUOROARACHIDONIC AND METHODS OF USE THEREOF US 61/644,970 Abandoned
NIDCR E-038-2013-1-US-01 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH13/466473 US CIP 13/466,473 8921340 Issued PDF
NCI E-117-2011-0-CA-05 Recombinant Immunotoxin Targeting Mesothelin CA National Stage 2835070 Issued
NCI E-117-2011-0-IN-29 Recombinant Immunotoxin Targeting Mesothelin IN National Stage 8854/CHENP/2013 Abandoned
NCI E-117-2011-0-EP-09 Recombinant Immunotoxin Targeting Mesothelin EP National Stage 12722586.0 Issued
NCI E-117-2011-0-JP-23 Recombinant Immunotoxin Targeting Mesothelin JP National Stage 2014-509467 Issued
NCI E-117-2011-0-AU-03 Recombinant Immunotoxin Targeting Mesothelin AU National Stage 2012253896 Issued
NCI E-117-2011-0-CN-24 Recombinant Immunotoxin Targeting Mesothelin CN National Stage 201280033583.7 Issued
NIAID E-131-2002-0-US-20 Methods of Treating and Preventing Colitis Involving IL-13 and NK-T Cells US DIV 13/464,323 8821866 Abandoned PDF
NCI E-117-2011-0-PCT-02 Recombinant Immunotoxin Targeting Mesothelin PCT PCT PCT/US2012/036456 Expired
NCI E-117-2011-0-KR-11 Recombinant Immunotoxin Targeting Mesothelin KR National Stage 10-2013-7032247 Abandoned
NCI E-117-2011-0-CL-06 Recombinant Immunotoxin Targeting Mesothelin CL National Stage 03182-2013 Abandoned
NCI E-117-2011-0-ID-27 Recombinant Immunotoxin Targeting Mesothelin ID National Stage W-00201305198 Abandoned
NCI E-117-2011-0-IL-28 Recombinant Immunotoxin Targeting Mesothelin IL National Stage 229198 Abandoned
NCI E-117-2011-0-PH-15 Recombinant Immunotoxin Targeting Mesothelin PH National Stage 1-2013-502264 Abandoned
NCI E-117-2011-0-SG-17 Recombinant Immunotoxin Targeting Mesothelin SG National Stage 201308179-9 Abandoned
NCI E-117-2011-0-MX-12 Recombinant Immunotoxin Targeting Mesothelin MX National Stage MX/a/2013/012905 Abandoned
NCI E-117-2011-0-MY-13 Recombinant Immunotoxin Targeting Mesothelin MY National Stage PI 2013702094 Abandoned
NCI E-117-2011-0-UA-19 Recombinant Immunotoxin Targeting Mesothelin UA National Stage 201313011 Abandoned
NCI E-117-2011-0-TH-18 Recombinant Immunotoxin Targeting Mesothelin TH National Stage 1301006329 Abandoned